Page 177 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C1.1. Descriptive characteristics of the epidemiologic studies considered relevant to KQ1 (continued)
Author Database Start End year Sample size Eligibility criteria
Year year
uid
55
Newcomer SEER, 1974 1994 33,086 White or African-American men, aged ≥35 yr with incident histologically-
1997 Seattle-Puget confirmed prostate cancer. Excluded cases identified through autopsy report
9302136 Sound only.
56
Stephenson SEER, Utah 1984 1993 8867 NR
1996 (different analytic
8608513 samples were used
for different
analyses)
57
Potosky SEER- 1986 1991 NR Prostate cancer patients aged ≥65 yr.
1995 Medicare
7530782
58
Klabunde SEER- 1986 1993 52,915 Black and White men, aged 65 or older, diagnosed with prostate cancer.
1998 Medicare Excluded men whose tumor stage was recorded as in situ, distant, or
9749657 unstaged, those with unknown tumor grade, those diagnosed with prostate
cancer by autopsy or only on death certificates, those with incomplete
Medicare claims data and those with racial/ethnic classification other than
White or Black.
59
Sheikh SEER- 1986 1996 NR Medicare beneficiaries aged ≥65 yr (for population rates); incident cases of
2002 Medicare prostate cancer (to define the population at risk of undergoing radical
11880074 prostatectomy)
60
Godley SEER- 1986 1996 43,989 Localized prostate cancer, aged 65-84 yr, enrolled in Medicare Part A or Part
2003 Medicare B for at least one month of the study period. Patients were excluded if they
14625261 had a prior cancer diagnosis, a second cancer diagnosed in the same month
as prostate cancer, had non-invasive disease, were missing the month of
diagnosis, were aged <65 yr, were neither Black or nor non-Hispanic White,
were diagnosed at death, had no Medicare coverage during the study period,
or were aged ≥85 yr at diagnosis. Patients with locally advanced, metastatic
or unstaged cancer were also excluded.
61
Zeliadt SEER- 1991 1999 90,128 White or African-American men, aged ≥65 with incident prostate cancer,
2004 Medicare clinically staged as localized or regional, eligible for Medicare Part A and Part
15596192 B, not enrolled in HMO at diagnosis. Patients with metastatic disease, those
who became ineligible for Medicare during the followup period and those with
an orchiectomy claim more than 3 months before diagnosis were excluded.
87
Warren SEER- 1991 2002 106,534 Men aged ≥65 diagnosed with prostate cancer stage I-IV, enrolled in
2008 Medicare [patients with claims Medicare Part A and Part B coverage for 2 months before and 12 months
18544740 for specific cancer after their diagnosis (i.e. Medicare claims up to 2003 were considered).
services] Excluded patients enrolled in managed care at any time during this 14-month
period.

C-6